![](/img/cover-not-exists.png)
Multicenter Randomized Open-Label Phase III Study Comparing Efficacy, Safety, and Tolerability of Conventional Carboplatin Plus Etoposide Versus Dose-Intensified Carboplatin Plus Etoposide Plus Lenograstim in Small-Cell Lung Cancer in “Extensive Disease” Stage
Heigener, David Felix, Manegold, Christian, Jäger, Elke, Saal, Johannes-Georg, Zuna, Ivan, Gatzemeier, UlrichVolume:
32
Language:
english
Journal:
American Journal of Clinical Oncology
DOI:
10.1097/coc.0b013e31817be954
Date:
February, 2009
File:
PDF, 362 KB
english, 2009